Chi Van Dang: "Editorial Policies Aacrjournals", , 9 February 2018 (2018-02-09), XP055450006, Retrieved from the Internet: URL:http://aacrjournals.org/content/author s/editorial-policies [retrieved on 2018-02-09] (B1)

WO-A2-98/39027 (B1)

MARK D. GIRGIS ET AL: "CA19-9 as a Potential Target for Radiolabeled Antibody-Based Positron Emission Tomography of Pancreas Cancer", INTERNATIONAL JOURNAL OF MOLECULAR IMAGING, vol. 2011, 1 January 2011 (2011-01-01), pages 1-9, XP055347674, ISSN: 2090-1712, DOI: 10.1155/2011/834515 (B1)

N. T. VIOLA-VILLEGAS ET AL: "Applying PET to Broaden the Diagnostic Utility of the Clinically Validated CA19.9 Serum Biomarker for Oncology", THE JOURNAL OF NUCLEAR MEDICINE, vol. 54, no. 11, 12 September 2013 (2013-09-12), pages 1876-1882, XP055347751, US ISSN: 0161-5505, DOI: 10.2967/jnumed.113.119867 (B1)

PRITSCH, O ET AL.: 'V Gene Usage By Seven Hybrids Derived From CD 5+ B- Cell Chronic Lymphocytic Leukemia And Displaying Autoantibody Activity.' BLOOD vol. 82, no. 10, 15 November 1993, pages 3103 - 3112, XP055320357 & DATABASE GENBANK Database accession no. PMID: 7693035 (B1)

SAWADA R ET AL: "Human monoclonal antibodies to sialyl-Lewis (CA19.9) with potent CDC, ADCC, and antitumor activity", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 17, no. 5, 1 March 2011 (2011-03-01), pages 1024-1032, XP002736040, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-10-2640 [retrieved on 2011-02-22] (B1)

SHITARA K ET AL: "APPLICATION OF ANTI-SIALYL LEA MONOCLONAL ANTIBODY, KM231, FOR IMMUNOTHERAPY OF CANCER", ANTICANCER RESEARCH - INTERNATIONAL JOURNAL OF CANCER RESEARCH AND TREATMENT, INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH, GR, vol. 11, no. 6, 1 November 1991 (1991-11-01), pages 2003-2013, XP008073114, ISSN: 0250-7005 (B1)

SOUZA, TA ET AL.: 'Peripheral B Cells Latently Infected With Epstein-Barr Virus Display Molecular Hallmarks Of Classical Antigen-Selected Memory B Cells.' PROC NATL ACAD SCI U S A. vol. 102, no. 50, 13 December 2005, pages 18093 - 18098, XP055320355 (B1)

UMASHANKAR K. BALLEHANINNA ET AL: "Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review", INDIAN JOURNAL OF SURGICAL ONCOLOGY, vol. 2, no. 2, 17 February 2011 (2011-02-17), pages 88-100, XP055347673, India ISSN: 0975-7651, DOI: 10.1007/s13193-011-0042-1 (B1)

US-A1- 2005 003 469 (B1)

US-A1- 2009 203 538 (B1)

US-A1- 2011 311 517 (B1)

US-A1- 2012 195 905 (B1)

US-A1- 2013 209 481 (B1)

VAN HEEL A ET AL: "Importance of pH in defining the specificity and clinical utility of monoclonal antibodies - an evaluation of two anti-CA 19-9 monoclonal antibodies", CANCER LETTERS, NEW YORK, NY, US, vol. 48, no. 2, 30 November 1989 (1989-11-30), pages 85-88, XP026178458, ISSN: 0304-3835, DOI: 10.1016/0304-3835(89)90041-4 [retrieved on 1989-11-30] (B1)

WO-A1-2009/033011 (B1)

MARK D GIRGIS ET AL: "Anti-CA19-9 Diabody as a PET Imaging Probe for Pancreas Cancer", JOURNAL OF SURGICAL RESEARCH, vol. 170, no. 2, October 2011 (2011-10), pages 169-178, XP028288974, ISSN: 0022-4804, DOI: 10.1016/J.JSS.2011.03.065 [retrieved on 2011-03-28] (B1)